Abstract
Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) are essential for responses to interferons (IFNs), most cytokines, and some growth factors. JAK/STAT signaling is not, however, sufficient for a full IFN-gamma response. Here, a convenient, robust, and quantitative flow cytometry-based kinome-wide siRNA screen has identified nine additional kinases as required for the IFN-gamma class II HLA response, seven for an antiviral response, and two for the cytopathic response to encephalomyocarditis virus (EMCV). As one example, inhibition of the IFN-gamma response by siRNA to ataxia telangiectasia-mutated (ATM) differentially affects a spectrum of IFN-gamma-stimulated mRNAs, with inhibitions being seen as early as 1 h after IFN-gamma stimulation. The implication of ATM, with its previously recognized function in chromatin decondensation, in the control of transcription early in the IFN-gamma response highlights both a role for ATM in cytokine responses and a possible correlation with the chromatin decondensation recently observed in response to IFN-gamma in mammalian cells. This work has, therefore, revealed the simplicity, power, and convenience of quantitative flow cytometry-based siRNA screens, a requirement for ATM and multiple additional kinases in the IFN-gamma response and a possible requirement for two of these kinases in the cytopathic response to EMCV.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Ataxia Telangiectasia Mutated Proteins
-
Cell Cycle Proteins / analysis
-
Cell Cycle Proteins / antagonists & inhibitors
-
Cell Cycle Proteins / genetics
-
Cell Line, Tumor
-
DNA-Binding Proteins / analysis
-
DNA-Binding Proteins / antagonists & inhibitors
-
DNA-Binding Proteins / genetics
-
Flow Cytometry / methods*
-
Histocompatibility Antigens Class II / immunology
-
Humans
-
Interferon-gamma / immunology*
-
Mice
-
Neoplasms / enzymology
-
Neoplasms / immunology
-
Phosphotransferases / analysis*
-
Phosphotransferases / antagonists & inhibitors
-
Phosphotransferases / genetics
-
Protein Serine-Threonine Kinases / analysis
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / genetics
-
RNA, Small Interfering / genetics
-
RNA, Small Interfering / pharmacology*
-
STAT1 Transcription Factor / analysis
-
STAT1 Transcription Factor / antagonists & inhibitors
-
STAT1 Transcription Factor / genetics
-
Tumor Suppressor Proteins / analysis
-
Tumor Suppressor Proteins / antagonists & inhibitors
-
Tumor Suppressor Proteins / genetics
-
Viruses / immunology
Substances
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Histocompatibility Antigens Class II
-
RNA, Small Interfering
-
STAT1 Transcription Factor
-
Tumor Suppressor Proteins
-
Interferon-gamma
-
Phosphotransferases
-
ATM protein, human
-
Ataxia Telangiectasia Mutated Proteins
-
Atm protein, mouse
-
Protein Serine-Threonine Kinases